Summary Investors and analysts have overestimated the market size for SBC-102 by at least 3-9x. Most sufferers of CESD can be treated by proper diet and common statins (i.e. Lipitor) without the need for a $300,000 drug. Management has now sold 95% of its stock, reducing combined holdings to less than 1% of outstanding –…

Read More